{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:15:43Z","timestamp":1789604143408,"version":"build-2803163510"},"reference-count":107,"publisher":"BMJ","issue":"10","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Clin Pathol"],"accepted":{"date-parts":[[2013,6,8]]},"published-print":{"date-parts":[[2013,10]]},"abstract":"<jats:p>The detection of neoplastic invasion remains the linchpin for a clear diagnosis of malignant mesothelioma. Cytology-only diagnosis of epithelioid mesothelioma on aspirated effusion fluid remains controversial. A major problem is poor sensitivity, although cytodiagnosis is achievable in many cases at a high order of specificity, especially when a large volume of effusion fluid is submitted for cytological evaluation, enabling the preparation of cell-block sections for immunohistochemical investigation and when the cytological findings can be correlated with imaging studies to assess the anatomical distribution of the lesion and evidence of nodularity of the pleural disorder and, in some cases, to demonstrate evidence of invasion. Although \u2018positive\u2019 and \u2018negative\u2019 immunohistochemical markers have proved remarkably effective in distinguishing between epithelioid mesothelioma and secondary carcinoma and other malignant tumours metastatic to serosal membranes, no mesothelial marker has 100% sensitivity and specificity for mesothelioma diagnosis, so that panels of \u2018positive\u2019 antibodies and markers with negative predictive value are required. At present, no tissue or serum marker (including the molecular detection of p16\/CDKN2A) has been proved to have sufficient specificity, consistency and reproducibility that it can replace evidence of invasion as the decisive marker for diagnosis when there is any uncertainty concerning a diagnosis of epithelioid mesothelioma and in the case of atypical fibrous lesions of the pleura (especially collagen-rich lesions, namely fibrous pleuritis vs desmoplastic mesothelioma), in which even the assessment of invasion can be problematical as illustrated in part 2 of this review.<\/jats:p>","DOI":"10.1136\/jclinpath-2012-201303","type":"journal-article","created":{"date-parts":[[2013,6,29]],"date-time":"2013-06-29T00:17:25Z","timestamp":1372465045000},"page":"847-853","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":103,"title":["Challenges and controversies in the diagnosis of mesothelioma: Part 1. Cytology-only diagnosis, biopsies, immunohistochemistry, discrimination between mesothelioma and reactive mesothelial hyperplasia, and biomarkers"],"prefix":"10.1136","volume":"66","author":[{"given":"Douglas W","family":"Henderson","sequence":"first","affiliation":[{"name":"Department of Surgical Pathology, SA Pathology, Flinders Medical Centre, Bedford Park, South Australia"},{"name":"Flinders University, Adelaide, South Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glen","family":"Reid","sequence":"additional","affiliation":[{"name":"Asbestos Diseases Research Institute (ADRI), Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven C","family":"Kao","sequence":"additional","affiliation":[{"name":"Asbestos Diseases Research Institute (ADRI), Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nico","family":"van Zandwijk","sequence":"additional","affiliation":[{"name":"Asbestos Diseases Research Institute (ADRI), Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonja","family":"Klebe","sequence":"additional","affiliation":[{"name":"Department of Surgical Pathology, SA Pathology, Flinders Medical Centre, Bedford Park, South Australia"},{"name":"Flinders University, Adelaide, South Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2013,6,27]]},"reference":[{"key":"2025092505450972000_66.10.847.1","doi-asserted-by":"crossref","unstructured":"Peto J Rake C Gilham C . Occupational, domestic and environmental mesothelioma risks in Britain: a case\u2013control study. London: HSE Books, 2009.","DOI":"10.1038\/sj.bjc.6604879"},{"key":"2025092505450972000_66.10.847.2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6604879"},{"key":"2025092505450972000_66.10.847.3","unstructured":"Australian Mesothelioma Registry 1st Annual Report. Mesothelioma in Australia 2011. Canberra: Safework Australia\/Comcare, 2012. http:\/\/www.mesothelioma-australia.com (accessed Feb 2013)."},{"key":"2025092505450972000_66.10.847.4","unstructured":"Australian Institute of Health and Welfare. Cancer incidence projections Australia, 2011 to 2020. Cancer Series number 66. Canberra, Australia, 2012. http:\/\/www.aihw.gov.au (accessed Feb 2013)."},{"key":"2025092505450972000_66.10.847.5","doi-asserted-by":"publisher","DOI":"10.5694\/mja11.10125"},{"key":"2025092505450972000_66.10.847.6","doi-asserted-by":"crossref","unstructured":"Henderson DW Shilkin KB Whitaker D . The pathology of mesothelioma, including immunohistology and ultrastructure. In: Henderson DW Shilkin KB Langlois SL Whitaker D . eds. Malignant mesothelioma. New York: Hemisphere, 1992:69\u2013139.","DOI":"10.1016\/S0012-3692(16)34358-6"},{"key":"2025092505450972000_66.10.847.7","doi-asserted-by":"crossref","unstructured":"Henderson DW Shilkin KB Whitaker D . Unusual histological types and anatomic sites of mesothelioma. In: Henderson DW Shilkin KB Langlois SL Whitaker D . eds. Malignant mesothelioma. New York: Hemisphere, 1992:140\u201366.","DOI":"10.1016\/S0012-3692(16)34358-6"},{"key":"2025092505450972000_66.10.847.8","unstructured":"Brambilla E Cagle PT Churg AM . International mesothelioma panel. In: Galateau-Sall\u00e9 F . ed. Pathology of malignant mesothelioma. London: Springer, 2006."},{"key":"2025092505450972000_66.10.847.9","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1007\/978-0-387-72114-9_12","article-title":"Neoplasms of the pleura","volume-title":"Dail and Hammar's pulmonary pathology","volume":"Vol 2","author":"Hammar","year":"2008"},{"key":"2025092505450972000_66.10.847.10","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.5858\/133.8.1317","article-title":"Guidelines for pathologic diagnosis of malignant mesothelioma: a consensus statement from the International Mesothelioma Interest Group","volume":"133","author":"Husain","year":"2009","journal-title":"Arch Pathol Lab Med"},{"key":"2025092505450972000_66.10.847.11","first-page":"1","article-title":"Guidelines for pathologic diagnosis of malignant mesothelioma: 2012 update of the consensus statement from the International Mesothelioma Interest Group","volume":"136","author":"Husain","year":"2012","journal-title":"Arch Pathol Lab Med"},{"key":"2025092505450972000_66.10.847.12","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/ajcp\/110.3.397","article-title":"Reactive mesothelial hyperplasia vs mesothelioma, including mesothelioma in situ: a brief review","volume":"110","author":"Henderson","year":"1998","journal-title":"Am J Clin Pathol"},{"key":"2025092505450972000_66.10.847.13","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1097\/00000478-200009000-00001","article-title":"The separation of benign and malignant mesothelial proliferations","volume":"24","author":"Churg","year":"2000","journal-title":"Am J Surg Pathol"},{"key":"2025092505450972000_66.10.847.14","doi-asserted-by":"crossref","unstructured":"Klebe S Henderson DW . Early stages of mesothelioma, screening and biomarkers. In: Tannapfel A . ed. Malignant mesothelioma. Berlin: Springer, 2011:169\u201393.","DOI":"10.1007\/978-3-642-10862-4_10"},{"key":"2025092505450972000_66.10.847.15","doi-asserted-by":"publisher","DOI":"10.5858\/arpa.2012-0112-RA"},{"key":"2025092505450972000_66.10.847.16","doi-asserted-by":"publisher","DOI":"10.1097\/01.pas.0000165529.78945.dc"},{"key":"2025092505450972000_66.10.847.17","doi-asserted-by":"publisher","DOI":"10.1007\/s00428-007-0375-x"},{"key":"2025092505450972000_66.10.847.18","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1007\/978-0-387-72114-9_14","article-title":"Cytopathology of pulmonary neoplasia","volume-title":"Dail and Hammar's pathology pathology","volume":"Vol 2","author":"Ohori","year":"2008"},{"key":"2025092505450972000_66.10.847.19","doi-asserted-by":"publisher","DOI":"10.1002\/dc.21303"},{"key":"2025092505450972000_66.10.847.20","doi-asserted-by":"publisher","DOI":"10.1002\/dc.21489"},{"key":"2025092505450972000_66.10.847.21","doi-asserted-by":"publisher","DOI":"10.1097\/PAT.0b013e32835bc848"},{"key":"2025092505450972000_66.10.847.22","doi-asserted-by":"publisher","DOI":"10.1378\/chest.111.1.106"},{"key":"2025092505450972000_66.10.847.23","doi-asserted-by":"crossref","unstructured":"Walters J Maskell NA . Biopsy techniques for the diagnosis of mesothelioma. In: Tannapfel A . ed. Malignant mesothelioma. Berlin: Springer-Verlag, 2011:45\u201355.","DOI":"10.1007\/978-3-642-10862-4_4"},{"key":"2025092505450972000_66.10.847.24","doi-asserted-by":"publisher","DOI":"10.1080\/01913120601172489"},{"key":"2025092505450972000_66.10.847.25","doi-asserted-by":"publisher","DOI":"10.1136\/oem.2007.034280"},{"key":"2025092505450972000_66.10.847.26","doi-asserted-by":"publisher","DOI":"10.1136\/thx.2007.087619"},{"key":"2025092505450972000_66.10.847.27","doi-asserted-by":"publisher","DOI":"10.1097\/MCP.0b013e3283474121"},{"key":"2025092505450972000_66.10.847.28","doi-asserted-by":"publisher","DOI":"10.1097\/JTO.0b013e3182114aa0"},{"key":"2025092505450972000_66.10.847.29","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2012.5535"},{"key":"2025092505450972000_66.10.847.30","doi-asserted-by":"publisher","DOI":"10.1378\/chest.11-2657"},{"key":"2025092505450972000_66.10.847.31","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2012-203043"},{"key":"2025092505450972000_66.10.847.32","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2559.2008.03099.x"},{"key":"2025092505450972000_66.10.847.33","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)13079-6"},{"key":"2025092505450972000_66.10.847.34","doi-asserted-by":"publisher","DOI":"10.1378\/chest.09-0884"},{"key":"2025092505450972000_66.10.847.35","doi-asserted-by":"publisher","DOI":"10.1510\/icvts.2010.255893"},{"key":"2025092505450972000_66.10.847.36","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00063109"},{"key":"2025092505450972000_66.10.847.37","first-page":"185","article-title":"Fine needle aspiration cytology of malignant mesothelioma","volume":"31","author":"Sterrett","year":"1987","journal-title":"Acta Cytol"},{"key":"2025092505450972000_66.10.847.38","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2009.02.023"},{"key":"2025092505450972000_66.10.847.39","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.23034"},{"key":"2025092505450972000_66.10.847.40","doi-asserted-by":"publisher","DOI":"10.1016\/j.athoracsur.2004.05.007"},{"key":"2025092505450972000_66.10.847.41","doi-asserted-by":"publisher","DOI":"10.1097\/JTO.0b013e31820ce2c7"},{"key":"2025092505450972000_66.10.847.42","unstructured":"Churg A Roggli V Galateau-Salle F . Mesothelioma. In: Travis WD Brambilla E M\u00fcller-Hermelink HK Harris C . eds. Pathology and genetics of tumours of the lung, pleura, thymus and heart. Lyon: IARC, 2004:128\u201336."},{"key":"2025092505450972000_66.10.847.43","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/dc.21146","article-title":"Evidence-based guidelines to optimize the selection of antibody panels in cytopathology: pleural effusions with malignant epithelioid cells","volume":"38","author":"Westfall","year":"2010","journal-title":"Diagn Cytopathol"},{"key":"2025092505450972000_66.10.847.44","doi-asserted-by":"publisher","DOI":"10.1080\/00313020802579250"},{"key":"2025092505450972000_66.10.847.45","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2559.2011.04031.x"},{"key":"2025092505450972000_66.10.847.46","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2559.2011.04036.x"},{"key":"2025092505450972000_66.10.847.47","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(20011115)92:10<2727::AID-CNCR1627>3.0.CO;2-B"},{"key":"2025092505450972000_66.10.847.48","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-9896(199910)189:2<251::AID-PATH412>3.0.CO;2-F"},{"key":"2025092505450972000_66.10.847.49","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2559.2003.01686.x"},{"key":"2025092505450972000_66.10.847.50","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2559.2006.02442.x"},{"key":"2025092505450972000_66.10.847.51","doi-asserted-by":"publisher","DOI":"10.1002\/dc.20208"},{"key":"2025092505450972000_66.10.847.52","doi-asserted-by":"publisher","DOI":"10.1309\/AJCPWFW7O1FVFLKT"},{"key":"2025092505450972000_66.10.847.53","doi-asserted-by":"publisher","DOI":"10.1002\/dc.21398"},{"key":"2025092505450972000_66.10.847.54","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.3800732"},{"key":"2025092505450972000_66.10.847.55","doi-asserted-by":"publisher","DOI":"10.1309\/AJCPP5R2ZJZKCLWN"},{"key":"2025092505450972000_66.10.847.56","doi-asserted-by":"publisher","DOI":"10.1038\/sj.modpathol.3801046"},{"key":"2025092505450972000_66.10.847.57","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0b013e318218985b"},{"key":"2025092505450972000_66.10.847.58","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2009.04.030"},{"key":"2025092505450972000_66.10.847.59","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1038\/modpathol.3800478","article-title":"Immunocytochemical detection of XIAP in body cavity effusions and washes","volume":"18","author":"Wu","year":"2005","journal-title":"Mod Pathol"},{"key":"2025092505450972000_66.10.847.60","doi-asserted-by":"publisher","DOI":"10.1309\/LX7NFRDXY1JQF9R1"},{"key":"2025092505450972000_66.10.847.61","doi-asserted-by":"crossref","first-page":"23","DOI":"10.5858\/2008-132-23-CMVBHU","article-title":"Cytologic malignancy versus benignancy: how useful are the \u2018newer\u2019 markers in body fluid cytology?","volume":"132","author":"Lyons-Boudreaux","year":"2008","journal-title":"Arch Pathol Lab Med"},{"key":"2025092505450972000_66.10.847.62","doi-asserted-by":"publisher","DOI":"10.1007\/BF01069743"},{"key":"2025092505450972000_66.10.847.63","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-200111000-00008"},{"key":"2025092505450972000_66.10.847.64","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2008.45"},{"key":"2025092505450972000_66.10.847.65","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.2010.076794"},{"key":"2025092505450972000_66.10.847.66","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)14794-0"},{"key":"2025092505450972000_66.10.847.67","doi-asserted-by":"publisher","DOI":"10.1016\/j.hoc.2005.09.007"},{"issue":"Suppl. 1","key":"2025092505450972000_66.10.847.68","doi-asserted-by":"crossref","first-page":"S109","DOI":"10.1016\/j.lungcan.2005.03.020","article-title":"Soluble mesothelin-related protein: a blood test for mesothelioma","volume":"49","author":"Robinson","year":"2005","journal-title":"Lung Cancer"},{"key":"2025092505450972000_66.10.847.69","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200511-1789OC"},{"key":"2025092505450972000_66.10.847.70","doi-asserted-by":"publisher","DOI":"10.1136\/thx.2006.068114"},{"key":"2025092505450972000_66.10.847.71","doi-asserted-by":"publisher","DOI":"10.1378\/chest.07-0013"},{"key":"2025092505450972000_66.10.847.72","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-07-0629"},{"key":"2025092505450972000_66.10.847.73","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/MCP.0b013e32812144bb","article-title":"Biomarkers for mesothelioma","volume":"13","author":"Scherpereel","year":"2007","journal-title":"Curr Opin Pulm Med"},{"key":"2025092505450972000_66.10.847.74","doi-asserted-by":"publisher","DOI":"10.1097\/JTO.0b013e318180477b"},{"key":"2025092505450972000_66.10.847.75","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200802-258OC"},{"key":"2025092505450972000_66.10.847.76","doi-asserted-by":"publisher","DOI":"10.1016\/j.athoracsur.2007.07.042"},{"key":"2025092505450972000_66.10.847.77","doi-asserted-by":"publisher","DOI":"10.1053\/j.semtcvs.2009.06.007"},{"key":"2025092505450972000_66.10.847.78","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-08-0422"},{"key":"2025092505450972000_66.10.847.79","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200907-1020OC"},{"key":"2025092505450972000_66.10.847.80","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1515\/CCLM.2010.306","article-title":"Biomarkers for early detection of mesothelioma in asbestos-exposed subjects","volume":"48","author":"Park","year":"2010","journal-title":"Clin Chem Lab Med"},{"key":"2025092505450972000_66.10.847.81","doi-asserted-by":"publisher","DOI":"10.1515\/cclm.2010.066"},{"key":"2025092505450972000_66.10.847.82","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-10-1929"},{"key":"2025092505450972000_66.10.847.83","doi-asserted-by":"publisher","DOI":"10.1097\/JTO.0b013e31820db377"},{"key":"2025092505450972000_66.10.847.84","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.39.6671"},{"key":"2025092505450972000_66.10.847.85","doi-asserted-by":"publisher","DOI":"10.1378\/chest.11-0129"},{"key":"2025092505450972000_66.10.847.86","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMe058176"},{"key":"2025092505450972000_66.10.847.87","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa051185"},{"key":"2025092505450972000_66.10.847.88","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-06-2144"},{"key":"2025092505450972000_66.10.847.89","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1177\/172460081002500307","article-title":"Comparison between plasma and serum osteopontin levels: usefulness in diagnosis of epithelial malignant pleural mesothelioma","volume":"25","author":"Cristaudo","year":"2010","journal-title":"Int J Biol Markers"},{"key":"2025092505450972000_66.10.847.90","doi-asserted-by":"publisher","DOI":"10.1097\/JTO.0b013e3182272294"},{"key":"2025092505450972000_66.10.847.91","first-page":"1427","article-title":"Impact of renal failure on the tumor markers of mesothelioma, N-ERC\/mesothelin and osteopontin","volume":"31","author":"Shiomi","year":"2011","journal-title":"Anticancer Res"},{"key":"2025092505450972000_66.10.847.92","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-06-0472"},{"key":"2025092505450972000_66.10.847.93","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2008.02.012"},{"key":"2025092505450972000_66.10.847.94","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1115050"},{"key":"2025092505450972000_66.10.847.95","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1213514"},{"key":"2025092505450972000_66.10.847.96","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1213514"},{"key":"2025092505450972000_66.10.847.97","first-page":"190","article-title":"Fibulin-3 as a biomarker for pleural mesothelioma","volume":"368","author":"Pass","year":"2013","journal-title":"N Engl J Med"},{"key":"2025092505450972000_66.10.847.98","doi-asserted-by":"publisher","DOI":"10.1007\/BF03256303"},{"key":"2025092505450972000_66.10.847.99","doi-asserted-by":"publisher","DOI":"10.1097\/PAT.0b013e3283445e67"},{"key":"2025092505450972000_66.10.847.100","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/64.5.1263"},{"key":"2025092505450972000_66.10.847.101","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2559.1992.tb00430.x"},{"key":"2025092505450972000_66.10.847.102","doi-asserted-by":"publisher","DOI":"10.1016\/0046-8177(95)90254-6"},{"key":"2025092505450972000_66.10.847.103","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2008.125"},{"key":"2025092505450972000_66.10.847.104","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2559.2000.00981.x"},{"key":"2025092505450972000_66.10.847.105","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.3800736"},{"key":"2025092505450972000_66.10.847.106","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1827.2007.02193.x"},{"key":"2025092505450972000_66.10.847.107","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2009.180"}],"container-title":["Journal of Clinical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jclinpath-2012-201303","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T12:45:21Z","timestamp":1758804321000},"score":1,"resource":{"primary":{"URL":"https:\/\/jcp.bmj.com\/lookup\/doi\/10.1136\/jclinpath-2012-201303"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6,27]]},"references-count":107,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2013,9,24]]},"published-print":{"date-parts":[[2013,10]]}},"alternative-id":["10.1136\/jclinpath-2012-201303"],"URL":"https:\/\/doi.org\/10.1136\/jclinpath-2012-201303","relation":{},"ISSN":["0021-9746","1472-4146"],"issn-type":[{"value":"0021-9746","type":"print"},{"value":"1472-4146","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,6,27]]}}}